Filtros de búsqueda

Lista de obras de

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

artículo científico publicado en 2020

Body mass index and breast cancer survival: a Mendelian randomization analysis

artículo científico publicado en 2017

Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial

artículo científico

Common germline polymorphisms associated with breast cancer-specific survival

artículo científico publicado en 2015

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3

artículo científico publicado en 2013

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial

artículo científico

Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study

artículo científico publicado en 2015

Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes

artículo científico publicado en 2016

Genome-wide association study of germline variants and breast cancer-specific mortality

artículo científico publicado en 2019

Identification of novel genetic markers of breast cancer survival

artículo científico publicado en 2015

Multi-omic machine learning predictor of breast cancer therapy response

artículo científico publicado en 2021

NRG1 fusions in breast cancer

scientific article published on 07 January 2021

Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes - what does it all mean?

artículo científico publicado en 2015

Pharmacogenetics of cancer chemotherapy

artículo científico publicado en 2006

Primary or Secondary Malignancy? Fingerprint Evidence

artículo científico publicado el 1 de octubre de 2003

Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial

artículo científico publicado en 2013

Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patien

artículo científico publicado en 2012

Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT

artículo científico publicado en 2020

The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes

artículo científico publicado en 2016

Trastuzumab-associated cardiac events in the Persephone trial

artículo científico publicado en 2016

ctDNA monitoring using patient-specific sequencing and integration of variant reads

artículo científico publicado en 2020